Reuters
FDA approves AstraZeneca's lung cancer drug as first-line treatmentReutersThe U.S. Food and Drug Administration has approved AstraZeneca Plc's drug, Iressa, as a first-line treatment for a common form of lung cancer. The drug was previously approved for use in non-small cell lung cancer patients only after they did not ...FDA approves targeted therapy for first-line treatment of patients with a type ...FDA.govall 2 news articles »
Monday, July 13, 2015
FDA approves AstraZeneca's lung cancer drug as first
By
Unknown
On
11:25 AM
Subscribe to:
Post Comments (Atom)